Imfinzi® Muscle-Invasive Bladder Cancer Trial Results NIAGARA – Guidelines+ Trials Spotlight

According to the American Cancer Society, bladder cancer accounts for approximately 4% of all cancers in the United States, making it the fourth most common cancer in men and less common in women. The likelihood of men developing bladder cancer in their lifetime is about 1 in 28, while for women, the chance is about […]